학술논문

Phase 1/2a trial of intrathecal 2-hydroxypropyl-beta-cyclodextrin (VTS-270) for the treatment of Niemann-Pick Disease, type C1
Document Type
Journal
Source
EUROPEAN JOURNAL OF HUMAN GENETICS; OCT 2018, 26 p405-p406, 2p. Supplement: S
Subject
Language
English
ISSN
14765438